Total parenteral nutrition in poor prognosis gestational trophoblastic disease.
From 1978 through 1984, 35 women received therapy for poor prognosis gestational trophoblastic disease (GTD) at Duke University Medical Center. Total parenteral nutrition (TPN) was utilized in nine patients (26%) for reasons including inadequate oral intake, nutritional depletion, and/or bone marrow suppression. Overall survival with follow-up ranging from 12 to 78 months was 88% for the TPN group and 70% for the non-TPN group (P = 0.38). Median duration of TPN therapy was 4 weeks (2-46 weeks). Intensity of therapy was comparable between the groups. Median weight gain of 0.15 kg/week for the TPN group was significantly greater than the 0.18/kg/week weight loss in the non-TPN group (P less than 0.001). Severe nutritional depletion represented by both low serum albumin (less than or equal to 2.5 gm/dl) and weight loss greater than or equal to 10% had a higher mortality rate than when only one of these factors existed (P = 0.006). Future studies need to further define the proper role of TPN in patients with poor prognosis GTD especially in those with severe nutritional deficits.
Bandy
L C
LC
Duke University Medical Center, Department of Obstetrics and Gynecology, Durham, North Carolina 27710.
Chin
N
N
Soper
J T
JT
Grant
J P
JP
Hammond
C B
CB
D000293:Adolescent; D000328:Adult; D001835:Body Weight; D005260:Female; D006801:Humans; D008875:Middle Aged; D010289:Parenteral Nutrition, Total; D011247:Pregnancy; D011379:Prognosis; D014328:Trophoblastic Neoplasms / Q000401:mortality / Q000628:therapy*; D014594:Uterine Neoplasms / Q000628:therapy*